Interleukin-17 SNPs and serum levels increase ulcerative colitis risk: A meta-analysis

World Journal of Gastroenterology

Volumn 20, Issue 42, 2014, Pages 15899-15909

  Li, Juan ^a   Tian, Hao ^a   Jiang, Hui Jun ^a   Han, Bin ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Interleukin 17; Meta analysis; Polymorphism; Serum; Ulcerative colitis

Indexed keywords

INTERLEUKIN 17; AUTACOID; IL17A PROTEIN, HUMAN; IL17F PROTEIN, HUMAN;

ALLELE; ARTICLE; ASIAN; CAUCASIAN; DISEASE ASSOCIATION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; META ANALYSIS; METHODOLOGY; POLYMERASE CHAIN REACTION; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; BLOOD; CASE CONTROL STUDY; COLITIS, ULCERATIVE; DISEASE COURSE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; PHENOTYPE; RISK; RISK ASSESSMENT; RISK FACTOR;

CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; DISEASE PROGRESSION; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-17; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 84912098938     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i42.15899     Document Type: Article

References (54)

1. Kornbluth A, Sachar DB. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2010; 105: 501-523; quiz 524 [PMID: 20068560 DOI: 10.1038/ajg.2009.727]
2. Tahara T, Shibata T, Nakamura M, Okubo M, Yamashita H, Yoshioka D, Yonemura J, Kmiya Y, Ishizuka T, Fujita H, Nagasaka M, Yamada H, Hirata I, Arisawa T. Host genetic factors, related to inflammatory response, influence the CpG island methylation status in colonic mucosa in ulcerative colitis. Anticancer Res 2011; 31: 933-938 [PMID: 21498716]
3. Rönnblom A, Samuelsson SM, Ekbom A. Ulcerative colitis in the county of Uppsala 1945-2007: Incidence and clinical characteristics. J Crohns Colitis 2010; 4: 532-536 [PMID: 21122556 DOI: 10.1016/j.crohns.2010.03.003]
4. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G, Benchimol EI, Panaccione R, Ghosh S, Barkema HW, Kaplan GG. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54.e42; quiz e30 [PMID: 22001864 DOI: 10.1053/j.gastro.2011.10.001]
5. Molodecky NA, Kaplan GG. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y) 2010; 6: 339-346 [PMID: 20567592]
6. Ng SC, Woodrow S, Patel N, Subhani J, Harbord M. Role of genetic and environmental factors in British twins with inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 725-736 [PMID: 21557397 DOI: 10.1002/ibd.21747]
7. Jantchou P, Monnet E, Carbonnel F. [Environmental risk factors in Crohn's disease and ulcerative colitis (excluding tobacco and appendicectomy)]. Gastroenterol Clin Biol 2006; 30: 859-867 [PMID: 16885870]
8. Thompson AI, Lees CW. Genetics of ulcerative colitis. Inflamm Bowel Dis 2011; 17: 831-848 [PMID: 21319274 DOI: 10.1002/ibd.21375]
9. Pearl DS, Shah K, Whittaker MA, Nitch-Smith H, Brown JF, Shute JK, Trebble TM. Cytokine mucosal expression in ulcerative colitis, the relationship between cytokine release and disease activity. J Crohns Colitis 2013; 7: 481-489 [PMID: 22974822 DOI: 10.1016/j.crohns.2012.07.022]
10. Hayashi R, Tahara T, Shiroeda H, Saito T, Nakamura M, Tsutsumi M, Shibata T, Arisawa T. Influence of IL17A polymorphisms (rs2275913 and rs3748067) on the susceptibility to ulcerative colitis. Clin Exp Med 2013; 13: 239-244 [PMID: 22955700 DOI: 10.1007/s10238-012-0206-5]
11. Weaver CT, Elson CO, Fouser LA, Kolls JK. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu Rev Pathol 2013; 8: 477-512 [PMID: 23157335 DOI: 10.1146/annurev-pathol-011110-130318]
12. Vidlak D, Kielian T. Differential effects of interleukin-17 receptor signaling on innate and adaptive immunity during central nervous system bacterial infection. J Neuroinflammation 2012; 9: 128 [PMID: 22704602 DOI: 10.1186/1742-2094-9-128]
13. Kolls JK, Lindén A. Interleukin-17 family members and inflammation. Immunity 2004; 21: 467-476 [PMID: 15485625 DOI: 10.1016/j.immuni.2004.08.018]
14. Ohman L, Dahlén R, Isaksson S, Sjöling A, Wick MJ, Sjövall H, Van Oudenhove L, Simrén M, Strid H. Serum IL-17A in newly diagnosed treatment-naive patients with ulcerative colitis reflects clinical disease severity and predicts the course of disease. Inflamm Bowel Dis 2013; 19: 2433-2439 [PMID: 23966065 DOI: 10.1097/MIB.0b013e3182a563cb]
15. Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol 2007; 148: 32-46 [PMID: 17328715 DOI: 10.1111/j.1365-2249.2007.03356.x]
16. Ryzhakov G, Lai CC, Blazek K, To KW, Hussell T, Udalova I. IL-17 boosts proinflammatory outcome of antiviral response in human cells. J Immunol 2011; 187: 5357-5362 [PMID: 21964025 DOI: 10.4049/jimmunol.1100917]
17. Hundorfean G, Neurath MF, Mudter J. Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease. Inflamm Bowel Dis 2012; 18: 180-186 [PMID: 21381156 DOI: 10.1002/ibd.21677]
18. Wendling D, Cedoz JP, Racadot E, Dumoulin G. Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis. Joint Bone Spine 2007; 74: 304-305 [PMID: 17369068 DOI: 10.1016/j.jbspin.2006.11.005]
19. Szkaradkiewicz A, Marciniak R, Chudzicka-Strugala I, Wasilewska A, Drews M, Majewski P, Karpinski T, Zwozdziak B. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients. Arch Immunol Ther Exp (Warsz) 2009; 57: 291-294 [PMID: 19578817 DOI: 10.1007/s00005-009-0031-z]
20. Qu N, Xu M, Mizoguchi I, Furusawa J, Kaneko K, Watanabe K, Mizuguchi J, Itoh M, Kawakami Y, Yoshimoto T. Pivotal roles of T-helper 17-related cytokines, IL-17, IL-22, and IL-23, in inflammatory diseases. Clin Dev Immunol 2013; 2013: 968549 [PMID: 23956763 DOI: 10.1155/2013/968549]
21. Schuett H, Schieffer B. Targeting cytokine signaling as an innovative therapeutic approach for the prevention of atherosclerotic plaque development. Curr Atheroscler Rep 2012; 14: 187-189 [PMID: 22467245 DOI: 10.1007/s11883-012-0246-z]
22. Feng T, Qin H, Wang L, Benveniste EN, Elson CO, Cong Y. Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production. J Immunol 2011; 186: 6313-6318 [PMID: 21531892]
23. McLean LP, Cross RK, Shea-Donohue T. Combined blockade of IL-17A and IL-17F may prevent the development of experimental colitis. Immunotherapy 2013; 5: 923-925 [PMID: 23998727 DOI: 10.2217/imt.13.87]
24. Rodríguez-Perálvarez ML, García-Sánchez V, Villar-Pastor CM, González R, Iglesias-Flores E, Muntane J, Gómez-Camacho F. Role of serum cytokine profile in ulcerative colitis assessment. Inflamm Bowel Dis 2012; 18: 1864-1871 [PMID: 22238172 DOI: 10.1002/ibd.22865]
25. Zhang X, Yu P, Wang Y, Jiang W, Shen F, Wang Y, Tu H, Yang X, Shi R, Zhang H. Genetic polymorphisms of interleukin 17A and interleukin 17F and their association with inflammatory bowel disease in a Chinese Han population. Inflamm Res 2013; 62: 743-750 [PMID: 23652560 DOI: 10.1007/s00011-013-0629-9]
26. Seiderer J, Elben I, Diegelmann J, Glas J, Stallhofer J, Tillack C, Pfennig S, Jürgens M, Schmechel S, Konrad A, Göke B, Ochsenkühn T, Müller-Myhsok B, Lohse P, Brand S. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): Upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis 2008; 14: 437-445 [PMID: 18088064 DOI: 10.1002/ibd.20339]
27. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010; 25: 603-605 [PMID: 20652370 DOI: 10.1007/s10654-010-9491-z]
28. Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 2006; 11: 193-206 [PMID: 16784338 DOI: 10.1037/1082-989X.11.2.193]
29. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA 2006; 295: 676-680 [PMID: 16467236 DOI: 10.1001/jama.295.6.676]
30. Liang XJ, Ma ZL, Zeng YJ. The clinical significance of interleukin 4 & interleukin 17's blood plasma level in patients with ulcerative colitis. Youjiang Yixue Zazhi 2005; 33: 6-8
31. Rovedatti L, Kudo T, Biancheri P, Sarra M, Knowles CH, Rampton DS, Corazza GR, Monteleone G, Di Sabatino A, Macdonald TT. Differential regulation of interleukin 17 and interferon gamma production in inflammatory bowel disease. Gut 2009; 58: 1629-1636 [PMID: 19740775 DOI: 10.1136/gut.2009.182170]
32. He Y, Li CM, Hou FX, Liu YJ. Expression of IL-17 type cytokin and IFN-? type cytokin in ulcerative clitis patients. Zhongguo Xiandai Yixue 2010; 17: 36-37
33. Xin L, Han Y, Wang ZH, Wang JH. Role of IL-17 and IL-23/IL-17 Immune-regulatory Pathway in the Pathogenesis of Ulcerative Colitis. Xinyixue Zazhi 2010; 20: 538-541, 534
34. Luo F, Wang C. Influence of olsalazine on TNF-A and IL-17 in patients with ulcerative colitis. Yixue Luntan Zazhi 2011; 32: 48-49
35. Zhen ZD, Wan XQ, Liu LY. Serum contents of IL-23 and IL-17 in the patients with ulcerative colitis and the clinical significance. Xibao Yu Fenzimianyixue Zazhi 2011; 27: 203-204
36. Chen JH. Clinical significance and serum contents of IL-23, IL-17 and IL25in the patients with inflammatory bowel disease. Zhongguo Linchang Shiyong Zazhi (Dianziban) 2012; 6: 698-699
37. Lin QC, Liao BX, Huang FN. Expression of interleukin IL-4, IL-17 in ulcerative colitis. Zhongguo Yixue Gongcheng Zazhi 2012; 2: 44-45
38. Liu LN. Serum level and significance of IL-17 in the children with infectious diarrhea and ulcerative colitis. Shiyong Yixue Zazhi 2013; 17: 141-142
39. Arisawa T, Tahara T, Shibata T, Nagasaka M, Nakamura M, Kamiya Y, Fujita H, Nakamura M, Yoshioka D, Arima Y, Okubo M, Hirata I, Nakano H. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J Clin Immunol 2008; 28: 44-49 [PMID: 17828618 DOI: 10.1007/s10875-007-9125-8]
40. Chen B, Zeng Z, Hou J, Chen M, Gao X, Hu P. Association of interleukin-17F 7488 single nucleotide polymorphism and inflammatory bowel disease in the Chinese population. Scand J Gastroenterol 2009; 44: 720-726 [PMID: 19263269 DOI: 10.1080/00365520902795430]
41. Kim SW, Kim ES, Moon CM, Park JJ, Kim TI, Kim WH, Cheon JH. Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease. Gut 2011; 60: 1527-1536 [PMID: 21672939 DOI: 10.1136/gut.2011.238477]
42. Yu PL, Zhang XF, Shen FC, Zhang HJ. Association between interleukin gene polymorphisms and iflammatory bowel diseases in Chinese patients. Shijie Huaren Xiaohua Zazhi 2012; 20: 875-882
43. Gaffen SL. An overview of IL-17 function and signaling. Cytokine 2008; 43: 402-407 [PMID: 18701318 DOI: 10.1016/j.cyto.2008.07.017]
44. Reynolds JM, Angkasekwinai P, Dong C. IL-17 family member cytokines: Regulation and function in innate immunity. Cytokine Growth Factor Rev 2010; 21: 413-423 [PMID: 21074482 DOI: 10.1016/j.cytogfr.2010.10.002]
45. Kono T, Korenaga H, Sakai M. Genomics of fish IL-17 ligand and receptors: A review. Fish Shellfish Immunol 2011; 31: 635-643 [PMID: 21134467 DOI: 10.1016/j.fsi.2010.11.028]
46. Cua DJ, Tato CM. Innate IL-17-producing cells: The sentinels of the immune system. Nat Rev Immunol 2010; 10: 479-489 [PMID: 20559326 DOI: 10.1038/nri2800]
47. Ajdukovic J, Tonkic A, Salamunic I, Hozo I, Simunic M, Bonacin D. Interleukins IL-33 and IL-17/IL-17A in patients with ulcerative colitis. Hepatogastroenterology 2010; 57: 1442-1444 [PMID: 21443100]
48. Yu P, Shen F, Zhang X, Cao R, Zhao X, Liu P, Tu H, Yang X, Shi R, Zhang H. Association of single nucleotide polymorphisms of IL23R and IL17 with ulcerative colitis risk in a Chinese Han population. PLoS One 2012; 7: E44380 [PMID: 22984500 DOI: 10.1371/journal.pone.0044380]
49. Hyun YS, Han DS, Lee AR, Eun CS, Youn J, Kim HY. Role of IL-17A in the development of colitis-associated cancer. Carcinogenesis 2012; 33: 931-936 [PMID: 22354874 DOI: 10.1093/carcin/bgs106]
50. Rouvier E, Luciani MF, Mattéi MG, Denizot F, Golstein P. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. J Immunol 1993; 150: 5445-5456 [PMID: 8390535]
51. Peluso I, Raguzzini A, Villano DV, Cesqui E, Toti E, Catasta G, Serafini M. High fat meal increase of IL-17 is prevented by ingestion of fruit juice drink in healthy overweight subjects. Curr Pharm Des 2012; 18: 85-90 [PMID: 22211683]
52. Fonseca-Camarillo G, Mendivil-Rangel E, Furuzawa-Carballeda J, Yamamoto-Furusho JK. Interleukin 17 gene and protein expression are increased in patients with ulcerative colitis. Inflamm Bowel Dis 2011; 17: E135-E136 [PMID: 21761512 DOI: 10.1002/ibd.21816]
53. Hölttä V, Klemetti P, Salo HM, Koivusalo A, Pakarinen M, Westerholm-Ormio M, Kolho KL, Vaarala O. Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis. J Pediatr Gastroenterol Nutr 2013; 57: 287-292 [PMID: 23974060 DOI: 10.1097/MPG.0b013e3182979252]
54. Zheng ZD, Wan XQ, Liu LY. Serum contents of IL-23 and IL-17 in the patients with ulcerative colitis and the clinical significance. Xibao Yu Fenzimianyixue Zazhi 2011; 27: 203-206 [PMID: 21560441]